InvestorsHub Logo
Followers 7
Posts 410
Boards Moderated 0
Alias Born 06/04/2014

Re: SF Wolf post# 1111

Tuesday, 02/21/2017 1:47:47 PM

Tuesday, February 21, 2017 1:47:47 PM

Post# of 21531
I left this quote out of my previous post about Ray Dirks blog article:

I can't wait to see the data that the company will be releasing in five months, April 2017, from their 148 patient Phase II placebo controlled trial. Multi modal efficacy of bryostatin targeting PKC epsilon, versus everyone else's drugs, that are just trying to hit one target. It isn't even a fair fight. Neurotrope's bryostatin, if approved, is a blockbuster for one of the largest unmet medical needs in the world today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News